Intrapartum cardiotocography patterns observed in suspected clinical and subclinical chorioamnionitis in term fetuses. by Galli, L et al.
For Peer Review
Intrapartum cardiotocography patterns observed in 
suspected clinical and subclinical chorioamnionitis in term 
fetuses.
Journal: The Journal of Obstetrics and Gynaecology Research
Manuscript ID JOGR-2019-0459.R2
Manuscript Type: Original Article
Date Submitted by the 
Author: n/a
Complete List of Authors: Galli, Letizia; St. George’s University Hospitals NHS Foundation Trust, ; 
Unit of Obstetrics and Gynecology, Azienda Unità Sanitaria Locale di 
Reggio Emilia - IRCCS,  
Dall'Asta, Andrea; University Hospital of Parma, Italy, Obstetrics and 
Gynecology
Whelehan, Virginia; St George’s University Hospitals NHS Foundation 
Trust
Archer, Abigail; St George’s University Hospitals NHS Foundation Trust
Chandraharan, Edwin
Keywords:
2.517 Obstetric Infections-Bacterial < 2.500 Obstetric Complications < 2 
Obstetrics, 2.600 Obstetrics: Fetal Assessment < 2 Obstetrics, 2.614 
Intrapartum Fetal Assesment < 2.600 Obstetrics: Fetal Assessment < 2 
Obstetrics, 2.615 Fetal Acid Base Status < 2.600 Obstetrics: Fetal 
Assessment < 2 Obstetrics
 
The Journal of Obstetrics and Gynaecology Research
The Journal of Obstetrics and Gynaecology Research
For Peer Review
TITLE PAGE
Intrapartum cardiotocography patterns observed in suspected clinical and subclinical 
chorioamnionitis in term fetuses.
AUTHORS
Letizia Galli1,2,3, Andrea Dall’Asta3,4, Virginia Whelehan1, Abigail Archer1, Edwin Chandraharan1
INSTITUTIONS
1St George’s University Hospitals NHS Foundation Trust, London, United Kingdom.
2Unit of Obstetrics and Gynecology, Azienda Unità Sanitaria Locale, Istituto di Ricovero e Cura a 
Carattere Scientifico (IRCCS), Azienda Unità Sanitaria Locale - Reggio Emilia, Italy.
3Department of Medicine and Surgery, Obstetrics and Gynecology Unit, University of Parma, Parma, 
Italy.
4Department of Surgery and Cancer, Institute of Reproductive and Developmental Biology, Imperial 
College London, United Kingdom.
ADDRESS FOR CORRESPONDENCE
Dr. Letizia Galli, MD
St. George’s University Hospitals NHS Foundation Trust, Blackshaw Road, London SW17 0QT, 
United Kingdom
Unit of Obstetrics and Gynecology, Azienda Unità Sanitaria Locale, Istituto di Ricovero e Cura a 
Carattere Scientifico (IRCCS), Azienda Unità Sanitaria Locale - Reggio Emilia, Italy
Department of Medicine and Surgery, Obstetrics and Gynecology Unit, University of Parma, Italy
Page 1 of 27
The Journal of Obstetrics and Gynaecology Research
The Journal of Obstetrics and Gynaecology Research
For Peer Review
Tel: +390521702434
E-mail: letizia.galli1986@gmail.com 
Short title
CTG and intrapartum chorioamnionitis
Number of words in the abstract: 214 words
Number of words in the manuscript (references excluded): 3036 words
Page 2 of 27
The Journal of Obstetrics and Gynaecology Research
The Journal of Obstetrics and Gynaecology Research
For Peer Review
Abstract
Aim
To evaluate the CTG features observed in suspected intrapartum clinical and subclinical 
chorioamnionitis in term fetuses according to the recently suggested criteria for the 
pathophysiological interpretation of the fetal heart rate and their correlation with perinatal 
outcomes.
Methods
Retrospective analysis of non-consecutive CTG traces. “CTG chorioamnionitis” diagnosed either 
based on a persistent rise in the baseline for the given gestation or on a persistent increase in the 
baseline fetal heart rate during labor >10% without preceding decelerations and in the absence of 
maternal pyrexia. Perinatal outcomes were compared among cases with no sign of 
chorioamnionitis, in those with only “CTG chorioamnionitis” and in those who developed clinical 
chorioamnionitis.
Results
2105 CTG traces analyzed. 356 fulfilled the CTG criteria for chorioamnionitis. Higher rates of APGAR 
< 7 at 1 and 5 minutes (21.6% vs 9.0% and 9.8% vs 2.0%, respectively, p <0.01 for both) and lower 
umbilical artery pH (7.14 + 0.11 vs 7.19 + 0.11, p <0.01) and an over 5-fold higher rate of NICU 
admission (16.6% vs 2.9%, p <0.01) were noted in the “CTG chorioamnionitis” group. Differences in 
the incidence of abnormal CTG patterns were noted between cases with clinical chorioamnionitis 
(89/356) and the “CTG chorioamnionitis group” (267/356).
Conclusions
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Intrapartum CTG features of suspected chorioamnionitis are associated with adverse perinatal 
outcomes.
Keywords
Fetal heart rate, inflammation, intrapartum fever, CTG pathophysiology, fetal heart monitoring.
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INTRODUCTION
The term chorioamnionitis refers to an acute inflammation of the amniotic membranes and the 
chorion of the placenta (1). Scientific evidence suggests that intrapartum chorioamnionitis is a major 
cause of non-hypoxic fetal compromise and adverse perinatal outcomes (2,3,4,5,6) being associated 
with a 5-fold higher risk of cerebral palsy (7). The diagnosis of chorioamnionitis is based on the 
clinical criteria described by Gibbs et al., which include maternal pyrexia and at least one among 
maternal or fetal tachycardia, uterine fundal tenderness, and purulent or foul amniotic fluid (8,9). 
Nevertheless, epidemiologic data suggest that up to 90% of cases of chorioamnionitis confirmed on 
pathology specimen of the membranes and the placenta occur in women with no overt sign of 
clinical (i.e. subclinical) chorioamnionitis (10,11). This illustrates the fact that chorioamnionitis is 
primarily a fetal disease and not a maternal disease, therefore signs and symptoms may not be 
consistently present in the mother. Conversely, maternal pyrexia may occur due to epidural 
anesthesia in a vast majority of cases (12,13,14), in the absence of histopathological evidence of 
chorioamnionitis (11,15).
Cardiotocography (CTG) is a test for fetal hypoxia and represents the most widely used tool for the 
intrapartum monitoring of the fetal wellbeing. Previous studies evaluated the relationship between 
CTG patterns and clinical or subclinical chorioamnionitis but could not demonstrate any role of the 
CTG in the diagnosis of chorioamnionitis (16-20). One of the reasons for these negative findings was 
attempting to correlate the CTG features that occur in intrapartum hypoxia (i.e. decelerations) to 
chorioamnionitis, which is a non-hypoxic pathway of fetal neurological injury. In addition, in these 
studies baseline tachycardia was defined as above 160 beats per minute (bpm), however term 
fetuses with a strong vagal dominance may not increase the baseline heart rate up to 160 bpm or 
above.
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The recently suggested criteria for the pathophysiological interpretation of the fetal heart rate (21) 
offer a unique opportunity to re-evaluate the association between chorioamnionitis and CTG 
abnormalities. According to the pathophysiology interpretation of the CTG, an increase in the fetal 
heart rate without preceding decelerations may reflect a ‘non-hypoxic’ cause of fetal compromise. 
Due to the poorly developed fetal blood-brain barrier and resultant impact of fetal systemic 
inflammatory response syndrome (FSIRS) on the brain, the autonomic and somatic nervous system 
centres may be affected. Therefore, abnormal CTG features such as reduced variability and lack of 
accelerations and cycling may be used as markers of chorioamnionitis. In this study we evaluated 
these “non-hypoxic” CTG characteristics and the perinatal outcomes within a selected cohort of 
fetuses with a suspicion of chorioamnionitis based on an increase in the baseline fetal heart rate 
without decelerations and in the abs nce of preceding maternal dehydration, tachycardia or 
pyrexia.
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METHODS
This was a retrospective study which included a non-consecutive series of women with non-
anomalous singleton term pregnancy who delivered at St. George’s University Hospitals NHS 
Foundation Trust, London, between 2014 and 2016.
According to the inclusion criteria of the study all women were in active labor, which was defined 
by means of a fully effaced, >3 cm dilatated cervix coupled with >3 contractions in 10 minutes 
recorded at tocography (22,23), and had ruptured membranes, which allowed continuous 
intrapartum CTG recording by internal transducer. At inclusion, all cases were at term pregnancy, 
which was defined by a gestational age between 37+0 and 41+6 weeks as determined by first 
trimester crown-rump length measurement, had cephalic presenting fetus and normal CTG 
according to the classification by the International Federation of Gynecology and Obstetrics 
(FIGO)(24). As a prerequisite for inclusion fetal growth was appropriate based on growth scan 
performed beyond 30 weeks or based on symphysis-fundal distance assessment performed at 36 to 
37 weeks and there was no history of maternal complications of the pregnancy such as preeclampsia 
or other hypertensive disorders of the pregnancy and diabetes.
All CTG traces were systematically evaluated by one single investigator (LG) with specific training on 
CTG interpretation and analyzed according to the FIGO guidelines and the newly developed 
interpretation of the CTG using fetal pathophysiology (21,25,26) in terms of baseline fetal heart rate 
(FHR) from labor onset until delivery and for CTG patterns including loss/absence of accelerations 
(i.e. abrupt  increase –– of the FHR above the baseline with onset to peak in less than 30 seconds 
and amplitude of more than 15 beats per minute (bpm) and lasting more than 15 seconds but less 
than 10 minutes), loss/absence of cycling (i.e. absence of alternative periods of active and quiet 
sleep indicating altered fetal behavioral state), loss/absence of variability (i.e. the oscillation in the 
FHR signal evaluated as the average bandwidth amplitude of the signal in 1-minute CTG segments), 
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baroreceptor-mediated or “variable” decelerations (i.e. characterized by a rapid fall in the FHR 
without any delay and a rapid recovery to the original baseline FHR and secondary to the 
compression of the umbilical cord), chemoreceptor-mediated or “late” decelerations (i.e. 
characterized by a gradual and slow recovery to the original baseline FHR even after cessation of 
uterine contractions and secondary to the accumulation of carbon dioxide and metabolic acids 
during hypoxia) and the presence of saltatory pattern (i.e. characterized by an increased variability 
with bandwidth value exceeding 25 bpm and lasting more than 30 minutes)  or sinusoidal patterns 
(i.e. a regular, smooth, undulating signal, resembling a sine wave, with amplitude of 5-15 bpm and 
a frequency of 3-5 cycles per minute, lasting for more than 30 minutes, which coincides with the 
absence of accelerations) (21,24). CTG traces were double checked by the supervisor (EC) to ensure 
inter-observer agreement.
According to the pathophysiological interpretation of the CTG, an increase >10% in the fetal heart 
rate without ongoing decelerations in the absence of preceding maternal tachycardia or pyrexia 
reflects a ‘non-hypoxic’ cause of fetal compromise such as fetal inflammatory response secondary 
to chorioamnionitis (21). Therefore, “CTG chorioamnionitis” was suspected either based on a 
persistent rise in the baseline FHR above the 95th percentile for the given gestation according to 
previously published reference ranges (27), in the absence of maternal dehydration and pyrexia, or 
based on the persistent increase in the baseline FHR >10% during labor, in the absence of preceding 
“repetitive” decelerations and of any other CTG indicator of hypoxia (24), compared to the baseline 
FHR recorded during the first 60 minutes of the CTG trace following the diagnosis of active labor. 
This 10% cut-off for raised baseline FHR was chosen as evidence of chorioamnionitis based on the 
fact that a 1°C rise in the body temperature increases the heart rate by approximately 10% 
(21,28,29,30). Only apyrexial women showing the aforementioned CTG features were considered at 
risk of chorioamnionitis and included for the study purposes. Clinical chorioamnionitis was 
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diagnosed in those women who eventually showed any sign of chorioamnionitis according to the 
Gibbs’ Criteria (1,8), while cases showing CTG features suspicious for chorioamnionitis without any 
evidence of maternal pyrexia or other signs or symptoms were labelled as “subclinical 
chorioamnionitis”. 
Cases where maternal pyrexia or tachycardia were transitory or were considered to be secondary 
to maternal dehydration, epidural analgesia and maternal urinary or respiratory tract infection or in 
which the diagnostic criteria for chorioamnionitis (1,8) were fulfilled before the onset of the CTG 
features suggestive of chorioamnionitis were excluded, as were cases in which the raised baseline 
FHR and/or the 10% increase in the baseline FHR was associated with preceding repetitive 
decelerations.
Information concerning maternal demographics and intrapartum and neonatal outcomes were 
retrieved from a dedicated electronic database for all the included cases.
Approval for this retrospective study was granted by the St. George’s Research & Enterprise Office. 
Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) version 20 (IBM 
Inc., Armonk, NY, USA). Data were shown as mean + standard deviation or as number (percentage). 
Categorical variables were compared using the Chi-square or Fisher exact test, while comparison of 
continuous variables included T test for independent sample and 2-tailed t tests. p <0.05 was 
considered as statistically significant.
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RESULTS
Overall, 2105 CTG traces were analyzed of which 356 (16.9%) fulfilled the CTG criteria for suspected 
chorioamnionitis. Pregnancy features and perinatal outcomes of cases with and without CTG 
suspicion of chorioamnionitis are summarized in Table 1. Within the “CTG chorioamnionitis” group, 
a significantly higher rate of nulliparae was noted (78.1% vs 67.6%, p <0.01), delivery occurred at 
significantly later gestation (40+3 + 1+2 vs 40+0 + 2+0, p <0.01) and neonatal weight was significantly 
higher (3524 + 469 vs 3384 + 494, p <0.01) compared to cases with no CTG suspicion of 
chorioamnionitis. Within this latter group a significantly lower rate of obstetric intervention was 
noted (44.8% vs 69.9%, p <0.01). Fetuses showing intrapartum CTG features suggestive of 
chorioamnionitis also showed significantly higher rates of APGAR <7 at 1 and 5 minutes (21.6% vs 
9%, p <0.01 and 9.8% vs 2.0%, p <0.01, respectively) and MSAF (38.2% vs 2.1%, p<0.01). Additionally, 
the “CTG chorioamnionitis” group showed lower umbilical artery pH (7.14 + 0.11 vs 7.19 + 0.11, p 
<0.01) but not higher rate of arterial pH less than 7.0 (p 0.20). NICU admission rate was over five-
fold higher in fetuses showing CTG features suggestive of chorioamnionitis (16.6% vs 2.9%, p <0.01) 
(Table 1). There was no case of intrapartum stillbirth or neonatal death.
Persistent loss of accelerations and the presence of chemoreceptor-mediated decelerations and 
baroreceptor-mediated decelerations were the most common abnormal CTG findings in the “CTG 
chorioamnionitis” group and were observed in 64.3%, 63.5% and 46.6%, respectively; persistently 
reduced variability and loss of cycling occurred in 30.9% and 33.1%, respectively, while saltatory and 
sinusoidal patterns were noted in 13.8% and 6.7%, respectively (Figure 1).
Within the “CTG chorioamnionitis” group, 89 (25%) fetuses eventually developed signs or symptoms 
of clinical chorioamnionitis, the remaining 267 (75%) being labelled as “subclinical chorioamnionitis” 
group. Subgroup analysis of the CTG patterns showed a significantly higher incidence in the loss of 
cycling (46.1% vs 28.8%, p <0.01) and persistently reduced variability (40.4% vs 27.7%, p 0.02) in the 
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“clinical” compared to the “subclinical chorioamnionitis” groups (Table 2). With regard to the 
relationship between abnormal CTG features, MSAF and neonatal outcomes loss/absence of 
variability was the only CTG abnormality which was significantly associated with all the considered 
adverse perinatal outcomes and also with lower umbilical cord arterial and venous pH (p <0.01 for 
both) but not with MSAF (Table 3). Loss/absence of accelerations and loss/absence of cycling were 
more common in those fetuses who experienced all the considered poor perinatal outcomes, 
however loss/absence of cycling was not associated with MSAF (p 0.17). Chemoreceptor-mediated  
decelerations were significantly related to low APGAR scores at 1 and 5 minutes (p <0.01 and 0.01 
respectively) and MSAF (p <0.01), while the presence of saltatory or sinusoidal patterns was variably 
associated with low APGAR at 1 and 5 minutes, MSAF fluid and NICU admission. Finally, no 
association was found between baroreceptor-mediated “variable” decelerations and any of the 
considered adverse perinatal outcomes within the study group.
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DISCUSSION
Data from our study suggest that an inappropriate (i.e. higher than expected) baseline fetal heart 
rate for the given gestational age and a persistent increase of the baseline in the absence of 
predisposing factors (i.e. suggestive of chorioamnionitis according to a pathophysiological 
interpretation of the CTG) are significantly associated with obstetric interventions, MSAF and 
adverse neonatal outcomes. Furthermore, a significant relationship between abnormal CTG 
patterns, clinical and subclinical chorioamnionitis and adverse neonatal outcomes has been 
demonstrated.
To our best knowledge, this is the first study that determined the features observed on the CTG 
trace in suspected chorioamnionitis based on the application of fetal pathophysiology without the 
use of CTG guidelines (24,31,32). These are based on “pattern recognition” and are primarily aimed 
at the detection of intrapartum hypoxia (21). On the other hand, chorioamnionitis is a fetal disease 
which causes fetal compromise through a “non-hypoxic” (i.e. inflammatory) pathway, therefore the 
CTG trace may not show the features described in standard guidelines on CTG interpretation. It is 
vital to appreciate that a post term fetus with an ongoing chorioamnionitis may increase its heart 
rate from 120 bpm to 155 bpm secondary to inflammatory response. Therefore, it may still be 
classified as normal according to CTG Guidelines which consider a baseline FHR between 110-160 
bpm as the normal range for all fetuses at term, irrespective of their gestational age.
A fetus who is exposed to intrapartum hypoxia would attempt to protect its myocardial workload 
by a reflex decrease in the FHR, termed as a deceleration (21,25,26,33). According to our hypothesis, 
unlike in hypoxia, where the increase in the catecholamine-mediated FHR occurs following the 
decelerations to protect the myocardium (21,33), in chorioamnionitis the increase of the baseline 
FHR is secondary to inflammatory mediators and raised metabolic rate secondary to ongoing 
inflammation and occurs in the absence of preceding decelerations. 
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Our study suggests that fetuses with CTG intrapartum features of chorioamnionitis have a higher 
incidence of poor Apgar score both at 1 and 5 minutes. This may be explained by the effect of 
inflammation on the muscle tone as well as on the fetal tracheo-bronchial tree, which may result in 
fetal congenital pneumonia and resultant low Apgar scores at 1 and 5 minutes. The significantly 
increased incidence of MSAF in fetuses with CTG features suggestive of chorioamnionitis may be 
explained by the fact that a fetus not only inhales the infected amniotic fluid into the lungs (i.e. 
develops congenital pneumonia and FSIRS) but also swallows the infected amniotic fluid leading to 
the onset of gastroenteritis and passage of meconium.
The occurrence of metabolic acidosis so defined by umbilical artery cord pH <7.00 was not 
significantly higher in fetuses showing CTG features suggestive of chorioamnionitis, however there 
was a trend towards lower umbilical arterial and venous pH within this group. This may be explained 
by the fact that in infection there is an increased metabolic demand leading to higher oxygen 
consumption compared to non-infected cases. Therefore, chorioamnionitis may lead to accelerated 
fall in pH during labor resulting in umbilical cord metabolic acidosis at birth (21,33,36,37).
With regard to the observed CTG features, our study suggests that cases showing clinical features 
of chorioamnionitis have an increased likelihood of developing absence of cycling and loss of 
baseline variability compared to those with subclinical chorioamnionitis. This may be explained by 
the detrimental effect of increased maternal temperature on the fetal hypothalamic thermo-
regulatory centre, with subsequent alteration of the fetal sleep-wake cycles manifesting with loss 
of cycling as well as depression of the fetal autonomic nervous system, which is associated with loss 
of baseline variability (21,38). The presence of baroreceptor-mediated and chemoreceptor-
mediated decelerations was not associated with lower umbilical arterial and venous cord pH in cases 
of clinical chorioamnionitis, however the presence of chemoreceptor-mediated late decelerations 
was related to an increased rate of MSAF. It is well-known that late decelerations occur due to 
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uteroplacental insufficiency (21,24,33). In chorioamnionitis, due to the presence of inflammation 
and placental villitis, the gaseous exchange across the placenta may be impaired leading to the onset 
of late decelerations.
Our study also shows that fetuses with features of suspected chorioamnionitis on the CTG trace 
have an increased likelihood of NICU admission. This may be secondary to poor postnatal adaptation 
as a result of ongoing inflammation and congenital pneumonia. 
The main strength of our study is represented by its original design, in which we first attempted to 
move away from the traditional CTG guidelines (24) and analyzed CTG according to a 
pathophysiological approach in order to demonstrate the feasibility of the intrapartum CTG 
suspicion of chorioamnionitis and detect its CTG features within a wide cohort of laboring women 
at term pregnancy. Additionally, optimal CTG recording was ensured by internal transducer in all 
cases and all CTG traces were systematically evaluated by the same two practitioners who had 
dedicated training on pathophysiological interpretation of the CTG.
We acknowledge that our study has limitations. In first instance, this is a retrospective analysis of 
CTG traces. Information concerning the group-B-Streptococcus (GBS) status and additional risk 
factors for intrauterine infection was not addressed, nevertheless this was a cohort of women with 
uncomplicated term pregnancy in which the prevalence of GBS is considered to be relatively 
constant (39,40). In the UK, routine screening for GBS is not carried out according to the current 
national guidelines (32). Additionally, it may be argued that the CTG traces in the non-
chorioamnionitis group were not analyzed, hence their features were not compared to those with 
chorioamnionitis. However, the aim of our study was to use a pathophysiological approach to 
determine the CTG characteristics of chorioamnionitis, and we believe that a comparative study 
with the ‘non-chorioamnionitis’ group can be performed only when the CTG features of 
chorioamnionitis have been determined.
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Another limitation is that placentae were not routinely sent for pathological examination, hence the 
correlation with histology could not be evaluated. However, the results of histopathological 
examination are not available to clinicians involved in everyday labour ward practice, therefore the 
purpose of our study was to determine the perinatal outcomes in fetuses with CTG features of 
suspected chorioamnionitis. Additionally, our dataset did not include data on inflammatory 
markers, such as white blood cells, which may confirm the diagnosis of clinical chorioamnionitis but 
are not tested during labor unless intrapartum infection is suspected. However, it is important to 
point out that increased inflammatory markers during labor are not specific indicators of 
chorioamnionitis.
The diagnostic criteria for “CTG chorioamnionitis” may also be subject of controversy, however 
evidence from our research has shown that when evaluating fetuses with no CTG features of 
hypoxia, those with CTG features suspicious for chorioamnionitis had worse perinatal outcomes 
compared to those with “appropriate” baseline FHR and, of note, almost one in four cases with “CTG 
chorioamnionitis” eventually showed clinical evidence of chorioamnionitis so defined according to 
the Gibbs’ criteria. Finally, we empirically chose a 10% increase in the baseline FHR as suspicious for 
chorioamnionitis, however we appreciate that fetal inflammatory response may not consistently 
elevate the baseline heart rate above the 10% in all cases.
In summary, fetuses with CTG features suggestive of chorioamnionitis have significantly higher rates 
of adverse perinatal outcomes and an over five-fold higher rate of NICU admission compared to 
fetuses with no suspicion of chorioamnionitis at CTG analysis. Additionally, different CTG features 
were observed between clinical and subclinical chorioamnionitis. Therefore, we believe that 
inappropriate baseline for the given gestational age and a persistent rise in the baseline fetal heart 
rate >10% without proceeding decelerations on the CTG trace in the absence of maternal pyrexia or 
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tachycardia should prompt suspicion of chorioamnionitis. In these cases, close intrapartum 
monitoring is warranted in order to avoid poor perinatal outcomes.
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Figure legends
Figure 1 – Algorithm for the management of suspected chorioamnionitis based on the 
cardiotocography (CTG) features by the application of fetal pathophysiology.
FHR: fetal heart rate; MSAF: meconium stained amniotic fluid.
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Table 1 – Pregnancy features and perinatal outcomes in the suspected cardiotocography (CTG) 
chorioamnionitis and in the non-suspected chorioamnionitis group.
Non-suspected 
chorioamnionitis
N 1749
Suspected CTG 
chorioamnionitis
N 356
P
Parity Nulliparae N 1183 (67.6%)
Pluriparae N 566 (32.4%)
Nulliparae N 278 (78.1%)
Pluriparae N 78 (21.9%)
<0.01
Gestation at delivery 40+0 + 2+0 40+3 + 1+2 <0.01
Induction of labor Yes N 803 (45.9%)
No N 946 (54.1%)
Yes N 176 (49.4%)
No N 180 (50.6%)
0.22
Mode of delivery SVD N 964 (55.2%)
ID N 584 (33.4%)
CS N 199 (11.4%)
SVD N 107 (30.1%)
ID N 157 (44.1%)
CS N 92 (25.8%)
<0.01
Birthweight 3384 + 494 3524 + 469 <0.01
APGAR < 7 I MIN 157 (9.0%) 77 (21.6%) <0.01
APGAR < 7 V MIN 35 (2.0%) 35 (9.8%) <0.01
Meconium stained amniotic 
fluid
37 (2.1%) 136 (38.2%) <0.01
Mean UA PH 7.19 + 0.11 7.14 + 0.11 <0.01
Mean UV PH 7.24 + 0.12 7.22 + 0.13 0.20
PH UA <7.00 24 (1.4%) 9 (2.5%) 0.20
NICU admission 51 (2.9%) 59 (16.6%) <0.01
UA – Umbilical artery
UV – Umbilical vein
NICU – Neonatal intensive care unit
SVD – Spontaneous vaginal delivery
ID – Instrumental delivery
CS – Caesarean delivery
Data presented as Number (percentage), mean + standard deviation or median (range)
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Table 2 – Suspected cardiotocography (CTG) chorioamnionitis group: comparison of the CTG features 
between clinical and subclinical chorioamnionitis.
CTG features Suspected CTG 
chorioamnionitis all 
cases
N 356
Clinical 
chorioamnionitis
N 89
Subclinical 
chorioamnionitis
N 267
p
Absence or loss of 
accelerations
229
(64.3%)
63
(70.8%)
166
(62.2%)
0.14
Absence or loss of 
cycling
118
(33.1%)
41
(46.1%)
77
(28.8%)
<0.01
Absence or loss of 
variability
110
(30.9%)
36
(40.4%)
74
(27.7%)
0.02
Baroreceptor 
decelerations
166
(46.6%)
42
(47.2%)
124
(46.4%)
0.90
Chemoreceptor 
decelerations
226
(63.5%)
53
(59.6%)
173
(64.8%)
0.37
Saltatory pattern 49
(13.8%)
10
(11.2%)
39
(14.6%)
0.42
Sinusoidal pattern 24
(6.7%)
5
(5.6%)
19
(7.1%)
0.63
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Table 3 – Suspected cardiotocography (CTG) chorioamnionitis group: correlation between abnormal CTG features, meconium stained amniotic 
fluid (MSAF) and neonatal outcomes.
MSAF – meconium stained amniotic fluid
UA – Umbilical artery
UV – Umbilical vein
MSAF APGAR <7 at I min APGAR <7 at V min MEAN UA pH MEAN UV pH NICU admnissionCTG features
Yes No p Yes No p Yes No p Yes No p Yes No p Yes No p
Absence or loss 
of 
accelerations
99/229
43.2%
37/127
29.1%
<0.01 69/229
30.1%
9/127
7.1%
<0.01 33/229
14.4%
2/127
1.6%
<0.01 7.12+0.11 7.19+0.01 <0.01 7.20+0.14 7.26+0.12 0.01 54/229
23.6%
5/127
3.9%
<0.01
Absence or loss 
of cycling
51/118
35.7%
85/238
43.2%
0.17 53/118
44.9%
25/238
10.5%
<0.01 27/118
22.9%
8/238
3.4%
<0.01 7.12+0.12 7.16+0.11 0.04 7.19+0.14 7.24+0.12 <0.01 43/118
36.4%
16/238
6.7%
<0.01
Absence or loss 
of variability
44/110
40%
92/246
37.3%
0.64 43/110
39.1%
35/246
14.2%
<0.01 28/110
25.4%
7/246
2.8%
<0.01 7.11+0.12 7.16+0.11 <0.01 7.18+0.14 7.24+0.13 <0.01 33/110
30%
26/246
10.6%
<0.01
Baroreceptor 
decelerations
66/166
39.8%
70/190
36.8%
0.57 43/166
25.9%
35/190
18.4%
0.08 18/166
10.8%
17/190
8.9%
0.55 7.13+0.11 7.16+0.11 0.14 7.22+0.13 7.22+0.14 0.78 23/166
13.8%
36/190
18.9%
0.20
Chemoreceptor 
decelerations
99/226
43.8%
37/130 
28.5%
<0.01 60/226
26.5%
18/130
13.8%
<0.01 29/226
12.8%
6/130
4.6%
0.01 7.13+0.11 7.16+0.12 0.09 7.21+0.13 7.22+0.14 0.64 43/226
19%
16/130
12.3%
0.10
Saltatory 
pattern
25/49
51% 
111/307
36.2%
0.047 17/49
34.7%
61/307
19.9%
0.02 9/49
18.3%
26/307
8.5%
0.03 7.12+0.12 7.15+0.11 0.34 7.21+0.13 7.22+0.14 0.87 14/49
28.5%
45/307
14.6%
0.02
Sinusoidal 
pattern
11/24
45.8% 
125/332
37.7%
0.42 11/24
45.8%
67/332
20.1%
<0.01 4/24
16.6%
31/332
9.3%
0.24 7.13+0.12 7.14+0.11 0.66 7.19+0.15 7.21+0.13 0.72 8/24
33.3%
51/332
15.4%
0.02
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NICU – Neonatal intensive care unit
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Figure 1 – Algorithm for the management of suspected chorioamnionitis based on the cardiotocography 
(CTG) features by the application of fetal pathophysiology. 
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